Epstein Secrets

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula E

kil Beshir Ulrich L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neera

l Ping Li Li Daokui Jason Li Yat-Sen Bernard Liautaud Zachary Lieberman Michael Liebreich Michel M. Lies Ernst Ligteringen Andrew Likierman Lin Yu Julio Linares Donald Lindsay Kristin Linklater Stefan Lippe Neal Lipschutz Vladimir Lisin Laura Liswood Peter Liu Peggy Liu Liu Chuanzhi Liu

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

n Li Daokui Ping Li Jason Li Yat-Sen Bernard Liautaud Zachary Lieberman Michael Liebreich Michel M. Lies Ernst Ligteringen Andrew Likierman Lin Yu Julio Linares Donald Lindsay Chairman and Chief Executive Officer Chief Risk Officer President and Chief Executive Officer General Secretary Dep

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

n Li Daokui Ping Li Jason Li Yat-Sen Bernard Liautaud Zachary Lieberman Michael Liebreich Michel M. Lies Ernst Ligteringen Andrew Likierman Lin Yu Julio Linares Donald Lindsay Chairman and Chief Executive Officer Chief Risk Officer President and Chief Executive Officer General Secretary Dep

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula Esco

r Leyen Li Daokui Ping Li Jason Li Yat-Sen Bernard Liautaud Zachary Lieberman Michael Liebreich Michel M. Liés Ernst Ligteringen Andrew Likierman Lin Yu Julio Linares Donald Lindsay Chairman and Chief Executive Officer Chief Risk Officer President and Chief Executive Officer General Secretary Deputy